42
Participants
Start Date
June 30, 2006
Primary Completion Date
July 31, 2010
Study Completion Date
November 30, 2011
rigosertib sodium
Patients will receive escalating doses of ON 01910.Na (250 mg/m2 to 4450 mg/m2) intravenously by 24 hour continuous infusion once every week (3 weeks per cycle), until evidence of disease progression, intolerable adverse events, or withdrawal of patient consent.
Albert Einstein Cancer Center, The Bronx
Traws Pharma, Inc.
INDUSTRY